Compare BNTC & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNTC | TG |
|---|---|---|
| Founded | 1995 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 360.7M | 353.3M |
| IPO Year | 2020 | 1994 |
| Metric | BNTC | TG |
|---|---|---|
| Price | $13.71 | $8.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $27.67 | N/A |
| AVG Volume (30 Days) | 86.2K | ★ 146.9K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 80.94 | ★ 151.06 |
| EPS | N/A | ★ 0.17 |
| Revenue | N/A | ★ $800,821,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $47.82 |
| Revenue Growth | N/A | ★ 8.29 |
| 52 Week Low | $9.85 | $6.25 |
| 52 Week High | $16.76 | $10.53 |
| Indicator | BNTC | TG |
|---|---|---|
| Relative Strength Index (RSI) | 71.65 | 50.03 |
| Support Level | $12.79 | $7.51 |
| Resistance Level | $14.35 | $8.24 |
| Average True Range (ATR) | 0.74 | 0.27 |
| MACD | 0.32 | 0.05 |
| Stochastic Oscillator | 96.74 | 58.00 |
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Tredegar Corp is engaged in the manufacture of aluminum extrusions and polyethylene and polypropylene plastic films. It produces surface protection films, packaging films and films for other markets. The company continues to have two reportable segments: Aluminum Extrusions and High Performance Films. The majority of the revenue is derived form the Aluminum Extrusions segment which produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets.